KESPEOX Trademark

Trademark Overview

On Monday, July 28, 2014, a trademark application was filed for KESPEOX with the United States Patent and Trademark Office. The USPTO has given the KESPEOX trademark a serial number of 86349906. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 1, 2024. This trademark is owned by Glaxo Group Limited. The KESPEOX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
kespeox

General Information

Serial Number86349906
Word MarkKESPEOX
Filing DateMonday, July 28, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 1, 2024
Registration Number5263194
Registration DateTuesday, August 15, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, March 1, 2024CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 15, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 15, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, July 12, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, April 19, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, April 19, 2017TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, October 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 18, 2016SOU EXTENSION 3 GRANTED
Monday, September 12, 2016SOU EXTENSION 3 FILED
Monday, September 12, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, April 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 23, 2016SOU EXTENSION 2 GRANTED
Wednesday, March 16, 2016SOU EXTENSION 2 FILED
Wednesday, April 20, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 16, 2016SOU TEAS EXTENSION RECEIVED
Thursday, September 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 8, 2015SOU EXTENSION 1 GRANTED
Tuesday, September 8, 2015SOU EXTENSION 1 FILED
Tuesday, September 8, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 28, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 3, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2015PUBLISHED FOR OPPOSITION
Wednesday, February 11, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 26, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, January 26, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 26, 2015DATA MODIFICATION COMPLETED
Wednesday, January 21, 2015DATA MODIFICATION COMPLETED
Tuesday, January 20, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 20, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 12, 2015ASSIGNED TO LIE
Wednesday, January 7, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, November 10, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 10, 2014LETTER OF SUSPENSION E-MAILED
Monday, November 10, 2014SUSPENSION LETTER WRITTEN
Monday, November 10, 2014ASSIGNED TO EXAMINER
Tuesday, August 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 31, 2014NEW APPLICATION ENTERED

Related Keywords

kespeox pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological